By Andrew Ceresney, Paul Rodel, Paul Rubin, Jonathan Tuttle and Ada Johnson ( August 30, 2019, 1:18 PM EDT) -- On Aug. 20, pharmaceutical company TherapeuticsMD Inc. settled charges by the U.S. Securities and Exchange Commission that the company had selectively disclosed market-moving information to sell-side analysts regarding potential approval of one of its drugs by the U.S. Food and Drug Administration. In the Matter of TherapeuticsMD is the first stand-alone Regulation Fair Disclosure action brought by the SEC in over five years....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.